Jones Christopher M
Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Ave, NW, Washington, D.C. 20052, United States.
Addict Behav. 2018 Nov;86:24-31. doi: 10.1016/j.addbeh.2018.07.008. Epub 2018 Jul 17.
Despite concerns over increasing harms associated with prescription opioid injection misuse, there is a paucity of research on the magnitude, characteristics, injection practices, and syringe sources for people who inject prescription opioids; limiting the implementation of targeted policy and programmatic initiatives.
Data from the 2003 through 2014 National Surveys on Drug Use and Health were used to estimate prescription opioid injection trends and examine risky injection practices and syringe sources for people who inject prescription opioids. Multivariable logistic regression was used to identify characteristics associated with prescription opioid injection.
Among people 12years or older, the rate of prescription opioid injection misuse increased from 1.6 per 1000 in 2003-2005 to 2.7 per 1000 in 2012-2014 (p value for trend <0.05). Groups with increased odds of prescription opioid injection included: males, non-Hispanic whites, having an annual household income <$50,000, the uninsured, people with Medicaid, and people with past-year use disorders for cocaine, heroin, or prescription opioids. Risky injection practices such as reusing a needle and sharing needles were common among people with a history of prescription opioid injection misuse.
This study found significant increases in prescription opioid injection misuse trends in the U.S. These findings underscore the need to bring to scale evidence-based interventions to increase the provision of medication-assisted treatment for opioid use disorders and expand access to comprehensive risk-reduction services for people who inject drugs.
尽管人们担心与处方阿片类药物注射滥用相关的危害不断增加,但对于注射处方阿片类药物的人群的规模、特征、注射行为和注射器来源的研究却很少;这限制了针对性政策和项目倡议的实施。
使用2003年至2014年全国药物使用和健康调查的数据来估计处方阿片类药物注射趋势,并检查注射处方阿片类药物的人群的危险注射行为和注射器来源。多变量逻辑回归用于确定与处方阿片类药物注射相关的特征。
在12岁及以上的人群中,处方阿片类药物注射滥用率从2003 - 2005年的每1000人1.6例增加到2012 - 2014年的每1000人2.7例(趋势p值<0.05)。处方阿片类药物注射几率增加的群体包括:男性、非西班牙裔白人、家庭年收入低于50,000美元者、未参保者、医疗补助受益者以及过去一年有可卡因、海洛因或处方阿片类药物使用障碍者。在有处方阿片类药物注射滥用史的人群中,重复使用针头和共用针头之类的危险注射行为很常见。
本研究发现美国处方阿片类药物注射滥用趋势显著增加。这些发现强调需要推广基于证据的干预措施,以增加对阿片类药物使用障碍的药物辅助治疗的提供,并扩大为注射吸毒者提供全面降低风险服务的机会。